TW202031887A - Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight - Google Patents

Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight Download PDF

Info

Publication number
TW202031887A
TW202031887A TW108106844A TW108106844A TW202031887A TW 202031887 A TW202031887 A TW 202031887A TW 108106844 A TW108106844 A TW 108106844A TW 108106844 A TW108106844 A TW 108106844A TW 202031887 A TW202031887 A TW 202031887A
Authority
TW
Taiwan
Prior art keywords
fat
burning
fat burning
fermentation
yeast
Prior art date
Application number
TW108106844A
Other languages
Chinese (zh)
Other versions
TWI690589B (en
Inventor
林詠翔
黃琡涵
Original Assignee
大江生醫股份有限公司
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 大江生醫股份有限公司 filed Critical 大江生醫股份有限公司
Priority to TW108106844A priority Critical patent/TWI690589B/en
Priority to CN201910357881.5A priority patent/CN111617218A/en
Application granted granted Critical
Publication of TWI690589B publication Critical patent/TWI690589B/en
Publication of TW202031887A publication Critical patent/TW202031887A/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/73Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/54Lauraceae (Laurel family), e.g. cinnamon or sassafras
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/81Solanaceae (Potato family), e.g. tobacco, nightshade, tomato, belladonna, capsicum or jimsonweed
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/88Liliopsida (monocotyledons)
    • A61K36/906Zingiberaceae (Ginger family)
    • A61K36/9068Zingiber, e.g. garden ginger
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/04Anorexiants; Antiobesity agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Mycology (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Obesity (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

The present invention provides a fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight. The fat burning ferment can effectively promote the decomposition of fat in fat cells, to reduce the gene expression level of PLIN1 and PPARG2 in fat cells to promote the decomposition of fatty oil droplets, and to promote the conversion of white fat cells to brown fat cells, which increases the ability to burn fat. The fat burning ferment is prepared by fermenting the apple, the ginger, the chili, and a cinnamon to yeast, lactic acid bacteria, and acetic acid bacteria for three-stage fermentation.

Description

燃脂發酵物及其製備方法與用於燃脂減肥的用途 Fat burning fermented product, preparation method thereof and use for fat burning and weight loss

本發明係關於一種燃脂發酵物及其製備方法與用於製備燃脂減肥之組合物的用途,尤其是一種燃脂發酵物用於促進脂肪分解、降低PLIN1基因的表現量、及提升PPARG2基因的表現量;其中,該燃脂發酵物係將由一蘋果、一薑、一辣椒、及一肉桂所組成之混合物以酵母菌、乳酸桿菌、及醋酸桿菌依序進行三段式發酵而獲得。 Present invention relates to a fermentation method for its preparation comprising one fat burning and the use for the preparation of fat burning diet composition, in particular a ferment for promoting fat burning lipolysis, reduced expression levels PLIN1 gene, genes and enhance PPARG2 Among them, the fat burning fermentation product will be obtained by three-stage fermentation of a mixture consisting of an apple, a ginger, a pepper, and a cinnamon with yeast, Lactobacillus, and Acetobacter in sequence.

世界衛生組織(World Health Organization,WHO)以「傳染病」形容快速蔓延的肥胖,並稱其為「全球肥胖症」(Globesity)。依據世界衛生組織統計,全球20強國中的美國,超過8成的成年男性、7成7的成年女性過重(BMI超過25),而亞洲的韓國,其男女過重與肥胖比例超過5成。隨著飲食習慣改變及生活品質改善,台灣的肥胖盛行率亦逐年上升,依據衛生福利部國民健康署所公布之「2013-2014年國民營養健康狀況變遷調查」,其中成人過重或肥胖盛行率43%,而男性與女性比率分別為48.9%和38.3%。也就是說,台灣人中平均每兩個男性就有一個過重或肥胖,平均女性則兩至三個就有一個過重或肥胖。 The World Health Organization (WHO) uses "infectious diseases" to describe the rapidly spreading obesity and calls it "Global Obesity" (Globesity). According to statistics from the World Health Organization, in the United States, among the top 20 countries in the world, more than 80% of adult men and 70% of adult women are overweight (BMI over 25), while South Korea in Asia has an overweight and obesity ratio of over 50%. With changes in eating habits and improved quality of life, the prevalence of obesity in Taiwan has also increased year by year. According to the "2013-2014 National Nutrition and Health Status Change Survey" published by the National Health Administration of the Ministry of Health and Welfare, the prevalence rate of adult overweight or obesity is 43 %, while the male to female ratios were 48.9% and 38.3%. In other words, one in two men in Taiwan is overweight or obese, and one in two to three women is overweight or obese.

肥胖會引起許多相關的合併症,如糖尿病、高血脂、睡眠呼吸中止、狹心症、退化性關節炎、尿酸過高,甚至某些癌症等,進而可能造成死亡,因此病態性肥胖病患的平均壽命比起正常體重者少了許多。目前治療肥胖最有 效的方法為手術治療,另外合法藥物(目前只有羅氏鮮)、運動、熱量控制、及低卡代餐等亦被證實是有效的方式。然而,除了手術治療之外,大部份的病患使用其他方法減肥,大多在減重治療結束後便會失去戒心而復胖,如此一瘦一胖的現象(溜溜球效應)而對身體的傷害更大。 Obesity can cause many related comorbidities, such as diabetes, hyperlipidemia, sleep apnea, angina, degenerative arthritis, hyperuricemia, and even certain cancers, which may lead to death. Therefore, morbidly obese patients The average life expectancy is much shorter than that of people of normal weight. Currently the most effective treatment for obesity The effective method is surgical treatment. In addition, legal drugs (currently only Roche fresh), exercise, calorie control, and low-calorie meal replacement have also been proven effective. However, in addition to surgical treatment, most patients use other methods to lose weight. Most patients lose their guard and regain weight after the weight loss treatment is over. Such a phenomenon of losing weight (yo-yo effect) has a serious impact on the body. It hurts more.

人體的脂肪細胞共分為白色脂肪細胞(亦稱為單房細胞)及棕色脂肪細胞兩種。其中白色脂肪細胞主要負責儲存能量,因此白色脂肪細胞的數量以及體積與一個體的肥胖現象息息相關,其中普通成人身體中大約有300億個脂肪細胞並重約13.5千克。該種細胞中含有一被細胞質所環繞的脂滴,脂肪主要會以三酸甘油酯和膽固醇酯的形式,以半液體的狀態被儲存在該脂滴中。白色脂肪細胞亦會分泌抵抗素、脂聯素以及瘦素,以調控個體的脂肪代謝。 Human fat cells are divided into two types: white fat cells (also known as unicellular cells) and brown fat cells. Among them, white adipocytes are mainly responsible for storing energy. Therefore, the number and volume of white adipocytes are closely related to the obesity phenomenon of an individual. Among them, there are about 30 billion fat cells in an average adult body and weighing about 13.5 kg. This kind of cell contains a lipid droplet surrounded by cytoplasm. The fat is mainly stored in the lipid droplet in a semi-liquid state in the form of triglycerides and cholesterol esters. White adipocytes also secrete resistin, adiponectin and leptin to regulate individual fat metabolism.

而褐色脂肪細胞(亦稱為多房細胞),相對於白色脂肪細胞,有相當大細胞質,脂滴則係分散於細胞各處,且該細胞含有大量的粒線體,因而外觀呈現褐色。褐色脂肪細胞的主要功能為快速燃燒脂肪以產生熱量並用以保持體溫,其中因冬眠動物及嬰兒體內含有較多的褐色脂肪組織,故棕色脂肪也稱為「嬰兒脂肪」。因此,若能夠將儲存油脂的白色細胞轉變成代謝油脂的褐色脂肪細胞,則可有效降低身體的脂肪量且不易復胖。 Compared with white adipocytes, brown adipocytes (also known as multilocular cells) have a relatively large cytoplasm. Lipid droplets are scattered throughout the cells, and the cells contain a large number of mitochondria, so their appearance is brown. The main function of brown fat cells is to burn fat quickly to generate heat and maintain body temperature. Among them, because hibernating animals and babies contain more brown fat tissue, brown fat is also called "baby fat". Therefore, if the white cells that store fat can be converted into brown fat cells that metabolize fat, the body's fat mass can be effectively reduced and it is not easy to gain weight.

綜上所述,因應現代人因生活及飲食習慣改變所面臨的肥胖及因肥胖造成之整體健康問題,且基於現代人生活水平提高且對於保健概念提高,研發一種能有效減少身體脂肪含量且減緩復胖的機會之有效成分組成的組合物,著實有其必要性。 In summary, in response to the obesity faced by modern people due to changes in living and eating habits and the overall health problems caused by obesity, and based on the improvement of modern people’s living standards and the improvement of the concept of health care, we have developed a system that can effectively reduce body fat content and slow down A composition composed of effective ingredients for the opportunity to gain weight is really necessary.

緣此,本發明之一目的在提供一種燃脂發酵物,其中該燃脂發酵物係由一蘋果、一薑、一辣椒、及一肉桂所組成之混合物經由一酵母菌 (Saccharomyces cerevisiae)、一乳酸桿菌(Lactobacillus plantarum)、及一醋酸桿菌(Acetobacter aceti)依序進行發酵而獲得。 For this reason, one object of the present invention is to provide a fat burning fermented product, wherein the fat burning fermented product is a mixture composed of an apple, a ginger, a pepper, and a cinnamon through a yeast ( Saccharomyces cerevisiae ), a Lactobacillus plantarum and Acetobacter aceti are obtained by fermentation in order.

本發明之又一目的在提供一種如前所述之燃脂發酵物用於製備一燃脂減肥之組合物的用途。 Another object of the present invention is to provide a use of the fat burning fermented product as described above for preparing a fat burning and weight loss composition.

本發明之另一目的在提供一種燃脂發酵物之製造方法,係包含:將一蘋果、一薑、一辣椒、及一肉桂以1:15-30:2-3:0.5之重量比均勻混合所組成之混合物經由一酵母菌、一乳酸桿菌、及一醋酸桿菌依序進行三階段發酵而獲得。 Another object of the present invention is to provide a method for producing a fat burning fermented product, which comprises: uniformly mixing an apple, a ginger, a pepper, and a cinnamon in a weight ratio of 1:15-30:2-3:0.5 The composed mixture is obtained by sequentially performing three-stage fermentation of a yeast, a lactobacillus, and an acetobacter.

在本發明之一實施例中,該酵母菌之添加量為0.8-1.2%(w/w);該乳酸桿菌之添加量為0.4-0.6%(w/w);該醋酸桿菌之添加量為4-6%(w/w);且該酵母菌係為BCRC20271之菌株;該乳酸桿菌係為BCRC910805之菌株;該醋酸桿菌係為BCRC12324之菌株;且該酵母菌、該乳酸桿菌、及該醋酸桿菌之發酵時間比為1-3:1-3:3-5。 In an embodiment of the present invention, the addition amount of the yeast is 0.8-1.2% (w/w); the addition amount of the lactobacillus is 0.4-0.6% (w/w); the addition amount of the acetobacter is 4-6%(w/w); and the yeast strain is a strain of BCRC20271; the lactobacillus strain is a strain of BCRC910805; the acetobacter strain is a strain of BCRC12324; and the yeast strain, the lactobacillus, and the acetic acid The fermentation time ratio of bacilli is 1-3:1-3:3-5.

在本發明之又一實施例中,該燃脂發酵物係促進脂肪細胞中脂肪的分解;且該燃脂發酵物之有效濃度為至少0.5%(v/v)。 In another embodiment of the present invention, the fat burning fermentation product promotes the decomposition of fat in fat cells; and the effective concentration of the fat burning fermentation product is at least 0.5% (v/v).

在本發明之另一實施例中,該燃脂發酵物係降低脂肪細胞中PLIN1基因的表現量、及/或提升脂肪細胞中PP4RG2基因的表現量;且該燃脂發酵物之有效濃度為至少0.5%(v/v)。 In another embodiment of the present invention, the fermentation-based fat burning reduced expression levels of genes PLIN1 adipocytes, and / or enhance expression levels in adipocytes PP4RG2 gene; and the effective concentration of the fermentation product is at least Ranzhi 0.5%(v/v).

本發明將蘋果、薑、辣椒、及肉桂之混合物以酵母菌、乳酸桿菌、及醋酸桿菌進行三段式發酵所得之燃脂發酵物,能直接且有效促進脂肪細胞中脂肪的分解、亦能夠有效的降低脂肪細胞中PLIN1基因的表現量,促使脂肪油滴變得容易分解,並能同時有效提升PPARG2基因的表現量,促進白色脂肪細胞轉化為棕色脂肪細胞,使得身體燃燒脂肪的能力上升。因此,本發明之燃脂發酵物能多方面地分解或消耗身體的脂肪,以達到更佳地減肥減脂功效。故, 本發明之燃脂發酵物可用於製備燃脂減肥之組合物的用途,且該組合物是一醫藥品、或一食品,可藉由口服、塗抹等方式給予一個體。 In the present invention, the fat-burning fermentation product obtained by three-stage fermentation of a mixture of apple, ginger, pepper, and cinnamon with yeast, lactobacillus, and acetobacter can directly and effectively promote the decomposition of fat in fat cells, and can also be effective It reduces the expression of PLIN1 gene in fat cells, promotes the decomposition of fatty oil droplets, and can effectively increase the expression of PPARG2 gene at the same time, promotes the conversion of white fat cells into brown fat cells, and increases the body's ability to burn fat. Therefore, the fat burning fermented product of the present invention can decompose or consume body fat in various ways, so as to achieve a better weight loss and fat reduction effect. Therefore, the fat-burning fermented product of the present invention can be used to prepare a fat-burning and weight-loss composition, and the composition is a medicine or a food, which can be administered to a body by oral, smearing or the like.

以下將配合圖式進一步說明本發明的實施方式,下述所列舉的實施例係用以闡明本發明,並非用以限定本發明之範圍,任何熟習此技藝者,在不脫離本發明之精神和範圍內,當可做些許更動與潤飾,因此本發明之保護範圍當視後附之申請專利範圍所界定者為準。 The following will further illustrate the embodiments of the present invention in conjunction with the drawings. The following examples are used to illustrate the present invention and are not intended to limit the scope of the present invention. Anyone familiar with the art will not depart from the spirit and spirit of the present invention. Within the scope, some changes and modifications can be made. Therefore, the scope of protection of the present invention shall be subject to the scope of the attached patent application.

圖1係為本發明之一實施例的燃脂發酵物促進脂肪分解的長條圖。與控制組比較下:**p值<0.01;***p值<0.001。與比較組比較下:##p值<0.01。 Fig. 1 is a bar graph of fat-burning fermented products promoting lipolysis according to an embodiment of the present invention. Compared with the control group: **p value<0.01; ***p value<0.001. Compared with the comparison group: ##p value<0.01.

圖2係為本發明之一實施例的燃脂發酵物降低PLIN1基因之表現量的長條圖。與控制組比較下:*p值<0.05;**p值<0.01。 Fig. 2 is a bar graph showing the reduction of the expression level of the PLIN1 gene in the fat burning fermented product of an embodiment of the present invention. Compared with the control group: *p value<0.05; **p value<0.01.

圖3係為本發明之一實施例的燃脂發酵物提升PPARG2基因之表現量的長條圖。與控制組比較下:*p值<0.05。 Fig. 3 is a bar graph showing that the fat burning fermented product enhances the expression level of the PPARG2 gene in an embodiment of the present invention. Compared with the control group: *p value<0.05.

本文中所使用數值為近似值,所有實驗數據皆表示在20%的範圍內,較佳為在10%的範圍內,最佳為在5%的範圍內。 The numerical values used herein are approximate values, and all experimental data are expressed in the range of 20%, preferably in the range of 10%, and most preferably in the range of 5%.

使用Excel軟體進行統計分析。數據以平均值±標準差(SD)表示,個此之間的差異以學生t檢驗(student's t-test)分析。 Use Excel software for statistical analysis. Data mean ± standard deviation (SD) represented by the difference between the two herein by Student t test (student's t -test) analysis.

蘋果(Malus pumila Mill.)為薔薇科(Rosaceae)蘋果屬(Malus)之喬木,又稱為文林果、文官果、陵果、柰等。原產於歐洲及亞洲西部的溫帶地區,台灣則於1960年代引進於梨山一帶山地栽種。蘋果果實為仁果,其大小、形狀、顏色及成熟季節隨品種而各有異,形狀普遍為球形,首尾兩端凹入且具 有花萼殘存之裂片,果期則多為7-10月。蘋果的果實具有解暑、開胃、醒酒、促進消化的功效。 Apple ( Malus pumila Mill. ) is a arbor of Rosaceae ( Malus ), also known as Wenlinguo, Wenguanguo, Lingguo, and so on. It is native to the temperate regions of Europe and western Asia, and Taiwan was introduced in the mountains of Lishan in the 1960s. The apple fruit is a pome, and its size, shape, color and ripening season vary with varieties. The shape is generally spherical, with concave head and tail ends with remaining lobes of the calyx. The fruiting period is mostly from July to October. The fruit of apple has the functions of relieving heat, appetizing, sobering, and promoting digestion.

薑(Zingiber officinale Roscoe)為薑科(Zingiberaceae)薑屬(Zingiber)之多年生草本植物,又稱為羌、茗荷、蘘荷等,原產於印度及東南亞。植株高約60-90公分;根莖肥厚、呈肉質塊狀,為淡黃色且外被有紅色鱗片,具芳香及辛辣味,常用作調味料,亦可生食、醃食、醬漬、或製成乾薑與糖薑等加工品。薑具有稱為Curcumin之黃色素及刺激性的揮發油,有發汗除風的藥效。 Ginger ( Zingiber officinale Roscoe ) is a perennial herb of the Zingiberaceae ( Zingiberaceae ) genus ( Zingiber ), also known as Qiang, Minghe, and Zingiber . It is native to India and Southeast Asia. The plant height is about 60-90 cm; the rhizome is thick, fleshy, lumpy, light yellow with red scales on the outside, with aromatic and spicy taste, often used as a seasoning, and can also be eaten raw, pickled, pickled, or made Processed products such as dried ginger and sugar ginger. Ginger has a yellow pigment called Curcumin and a pungent volatile oil, which has the medicinal effect of sweating and removing wind.

辣椒(Capsicum annum Linn.)為茄科(Solanaceae)辣椒屬(Capsicum)之一年生或有限多年生草本植物,又稱為番仔薑、番椒、海椒、牛角椒或、長辣椒。原產於中南美洲之墨西哥、哥倫比亞一帶,現在普遍栽培於世界各地。辣椒果實為漿果,通常為下垂狀且呈狹圓錐形,未成熟時為綠色,成熟後則轉變為朱紅色,表面有光澤,為中空且無汁,具有辛辣味,其中含有許多呈扁腎形之種子,種子長約0.2-0.4公分,且呈淡黃色。辣椒果實具有溫中散寒、開胃促進消化等功效食 Capsicum ( Capsicum annum Linn. ) is an annual or limited perennial herbaceous plant in the Capsicum genus ( Capsicum ) of the Solanaceae family ( Solanaceae ), and is also known as ginger, pepper, sea pepper, horn pepper or long pepper. It is native to Mexico and Colombia in Central and South America, and is now commonly cultivated all over the world. Pepper fruits are berries, usually drooping and narrowly conical. They are green when they are immature, and turn to vermilion when they are ripe. They have a shiny surface, are hollow and juiceless, and have a pungent taste. Many of them are flat kidney-shaped. The seeds are about 0.2-0.4 cm long and are light yellow. Pepper fruit has the functions of warming the middle and dispelling cold, appetizing and promoting digestion.

肉桂(Cinnamomum cassia Presl)為樟科(Lauraceae)樟屬(Cinnamomum)之中等大喬木,又稱為玉桂、桂枝、桂皮、官桂、桂心、陰香、連桂等。原產於中國熱帶及亞熱帶地區,現今台灣、印度、寮國、越南至印度尼西亞等地皆有栽種。肉桂之樹皮呈灰褐色,老樹皮厚達1.3公分;葉則呈長橢圓形至披針形,葉邊緣呈軟骨質且內卷,葉表面具有革質,為綠色且具有光澤,背面則為淡綠色,疏被友黃色短絨毛。葉、枝及樹皮等可供香料及藥用,具有散寒、止痛、化瘀、活血的功效。 Cinnamon (Cinnamomum cassia Presl) Lauraceae (Lauraceae) cinnamon (Cinnamomum) among other large trees, also known as cinnamon, cassia twig, cinnamon, Guan Gui, Gui Xin, Yin Hong, even Guangxi and other. It is native to tropical and subtropical regions of China, and is now cultivated in Taiwan, India, Laos, Vietnam and Indonesia. The bark of cinnamon is gray-brown, and the old bark is 1.3 cm thick; the leaves are oblong to lanceolate, the edges of the leaves are cartilaginous and involute, the surface of the leaves is leathery, green and shiny, and the back is light green. Sparse quilt yellow short hair. The leaves, branches and bark can be used as spices and medicinal purposes, and have the effects of dispelling cold, relieving pain, removing blood stasis and promoting blood circulation.

如本文中所使用的,用語「燃脂發酵物」意為蘋果、薑、辣椒、及肉桂磨碎後所組成之混合物以酵母菌、乳酸桿菌、及醋酸桿菌依序進行一三 段式發酵而獲得,其中該酵母菌之添加量為0.8-1.2%(w/w);該乳酸桿菌之添加量為0.4-0.6%(w/w);該醋酸桿菌之添加量為4-6%(w/w)。 As used herein, the term "fat burning fermented product" means that a mixture of apples, ginger, peppers, and cinnamon after being grated is processed by yeast, lactobacillus, and acetobacter in sequence. Obtained by stage fermentation, wherein the addition amount of the yeast is 0.8-1.2% (w/w); the addition amount of the lactobacillus is 0.4-0.6% (w/w); the addition amount of the acetobacter is 4 6%(w/w).

依據本發明,有關微生物發酵反應的操作程序與參數條件等是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the operating procedures and parameter conditions related to the microbial fermentation reaction fall within the scope of professionalism and routine technology of those who are familiar with the technology.

依據本發明,醫藥品可利用熟習此技藝者所詳知的技術而被製造成一適合於非經腸道地(parenterally)或局部地(topically)投藥的劑型,這包括,但不限於:注射品(injection)[例如,無菌的水性溶液(sterile aqueous solution)或分散液(dispersion)]、無菌的粉末(sterile powder)、外部製劑(external preparation)以及類似之物。 According to the present invention, the medicine can be manufactured into a dosage form suitable for parenterally or topically by using techniques well known to those skilled in the art. This includes, but is not limited to: injections (injection) [for example, a sterile aqueous solution or dispersion], a sterile powder, an external preparation, and the like.

依據本發明,醫藥品可進一步包含有一被廣泛地使用於藥物製造技術之醫藥上可接受的載劑(pharmaceutically acceptable carrier)。例如,該醫藥上可接受的載劑可包含一或多種選自於下列的試劑:溶劑(solvent)、緩衝液(buffer)、乳化劑(emulsifier)、懸浮劑(suspending agent)、分解劑(decomposer)、崩解劑(disintegrating agent)、分散劑(dispersing agent)、黏結劑(binding agent)、賦形劑(excipient)、安定劑(stabilizing agent)、螯合劑(chelating agent)、稀釋劑(diluent)、膠凝劑(gelling agent)、防腐劑(preservative)、潤濕劑(wetting agent)、潤滑劑(lubricant)、吸收延遲劑(absorption delaying agent)、脂質體(liposome)以及類似之物。有關這些試劑的選用與數量是落在熟習此項技術之人士的專業素養與例行技術範疇內。 According to the present invention, the medicine may further include a pharmaceutically acceptable carrier which is widely used in medicine manufacturing technology. For example, the pharmaceutically acceptable carrier may include one or more reagents selected from the group consisting of solvents, buffers, emulsifiers, suspending agents, decomposers ), disintegrating agent, dispersing agent, binding agent, excipient, stabilizing agent, chelating agent, diluent , Gelling agent, preservative, wetting agent, lubricant, absorption delaying agent, liposome and the like. The selection and quantity of these reagents fall within the scope of professionalism and routine techniques of those who are familiar with this technique.

依據本發明,該醫藥上可接受的載劑包含有一選自於由下列所構成之群組中的溶劑:水、生理鹽水(normal saline)、磷酸鹽緩衝生理鹽水(phosphate buffered saline,PBS)、含有醇的水性溶液(aqueous solution containing alcohol)以及它們的組合。 According to the present invention, the pharmaceutically acceptable carrier contains a solvent selected from the group consisting of water, normal saline (normal saline), phosphate buffered saline (PBS), Aqueous solution containing alcohol and combinations thereof.

依據本發明,該醫藥品可以一選自於由下列所構成之群組中的非經腸道途徑(parenteral routes)來投藥:皮下注射(subcutaneous injection)、表皮 內注射(intraepidermal injection)、皮內注射(intradermal injection)以及病灶內注射(intralesional injection)。 According to the present invention, the drug can be administered by a parenteral route selected from the group consisting of: subcutaneous injection, epidermal injection Intraepidermal injection, intradermal injection and intralesional injection.

依據本發明,食品產品可被當作食品添加物(food additive),藉由習知方法於原料製備時添加,或是於食品的製作過程中添加,而與任一種可食性材料配製成供人類與非人類動物攝食的食品產品。 According to the present invention, a food product can be used as a food additive, which is added during the preparation of raw materials by a conventional method, or added during the production of food, and is formulated with any edible material for supply Food products consumed by humans and non-human animals.

依據本發明,食品產品的種類包括但不限於:飲料(beverages)、發酵食品(fermented foods)、烘培產品(bakery products)、健康食品(health foods)以及膳食補充品(dietary supplements)。 According to the present invention, the types of food products include, but are not limited to: beverages, fermented foods, bakery products, health foods, and dietary supplements.

本發明提供一種燃脂發酵物及其製備方法與其用於燃脂減肥的用途,本發明之燃脂發酵物是將蘋果、薑、辣椒、及肉桂之混合物以酵母菌、乳酸桿菌、及醋酸桿菌依序進行三段式發酵而獲得,其中該酵母菌為BCRC20271之菌株、該乳酸桿菌為BCRC910805之菌株、該醋酸桿菌為BCRC12324之菌株。本發明之燃脂發酵物可有效促進脂肪細胞中脂肪的分解、降低脂肪細胞中PLIN1基因的表現量、以及提升PPARG2基因的表現量。 The present invention provides a fat burning fermented product and its preparation method and its use for fat burning and weight loss. The fat burning fermented product of the present invention is a mixture of apple, ginger, pepper, and cinnamon with yeast, lactobacillus, and acetobacter It is obtained by sequentially performing three-stage fermentation, wherein the yeast is a strain of BCRC20271, the lactobacillus is a strain of BCRC910805, and the acetobacter is a strain of BCRC12324. The fat burning fermented product of the present invention can effectively promote the decomposition of fat in adipocytes, reduce the expression level of PLIN1 gene in adipocytes, and increase the expression level of PPARG2 gene.

同時,本發明用於燃脂減肥之組合物,亦可包含一有效量之燃脂發酵物及一醫藥上可接受之載體,該組合物係一醫藥品、或一食品。 At the same time, the composition for fat burning and weight loss of the present invention can also include an effective amount of fat burning ferment and a pharmaceutically acceptable carrier, and the composition is a medicine or a food.

以下將詳細說明本發明燃脂發酵物之詳細製備方法、該燃脂發酵物促進脂肪分解之功效的測試、以及調控PLIN1基因及PPARG2基因表現量之功效的測試,以證實該減脂發酵物可有效促進脂肪細胞中脂肪的分解、降低脂肪細胞中PLIN1基因的表現量、以及提升PPARG2基因的表現量。 The detailed preparation method of the fat-burning fermented product of the present invention, the test of the effect of the fat-burning fermented product to promote lipolysis, and the test of the effect of regulating the expression of the PLIN1 gene and PPARG2 gene will be described in detail below to confirm that the fat-reducing fermented product can Effectively promote the breakdown of fat in fat cells, reduce the expression of PLIN1 gene in fat cells, and increase the expression of PPARG2 gene.

實施例1 本發明之燃脂發酵物的製備方法Example 1 Preparation method of fat burning fermentation product of the present invention

在本發明一實施例中,將蘋果的果實、薑的根莖、辣椒的果實、及肉桂的樹皮粗碎後,以1:15-30:2-3:0.5之重量比均勻混合,於95℃下加熱1.5小時後,將該混合溶液冷卻至低於40℃供後續三段式發酵使用;其中,蘋果較佳為富士蘋果,其果膠含量最高。首先,於該混合溶液中植入1%(w/w)之酵母 菌(Saccharomyces cerevisiae,購買於生物資源保存與研究中心,台灣,編號為BCRC20271),菌數優選為1x1010cfu/g,於室溫下進行前發酵24小時,實際時間視發酵狀態而異。接著直接植入0.5%(w/w)之乳酸桿菌(Lactobacillus plantarum TCI028,專利寄存於生物資源保存與研究中心,台灣,編號為BCRC910805),菌數優選為1x1011cfu/g,於室溫下進行後發酵24小時,實際時間視發酵狀態而異。接著再直接植入5%(w/w)之醋酸桿菌(Acetobacter sp.,購買於生物資源保存與研究中心,台灣,編號為BCRC12324),菌數優選為1x109cfu/g,於室溫下進行深層發酵3-5天,實際時間視發酵狀態而異;其中,乳酸桿菌TCI028係已於中華民國專利申請號第106145146號完成專利寄存,此三種菌之發酵依序為:酵母菌、乳酸桿菌、醋酸桿菌,且無法前後對調,最後在不移除此三種菌之情況下,使用設定的糖度範圍<4°、pH<4等規格,如檢驗符合該規格,則判定發酵完成並得到發酵液。接著,將該發酵液於45-70℃進行減壓濃縮,並以40-200 mesh網篩過濾,再添加1%檸檬酸及40%異麥芽寡糖調整規格後於95℃下加熱1.5小時進行滅菌,即得到本發明之燃脂發酵物,其中藉由微生物發酵製成,使蘋果、薑、辣椒、及肉桂混合物中之效性物質大量釋出。 In an embodiment of the present invention, the apple fruits, ginger rhizomes, capsicum fruits, and cinnamon bark are coarsely crushed, and then mixed uniformly in a weight ratio of 1:15-30:2-3:0.5, at 95°C After heating for 1.5 hours, the mixed solution is cooled to below 40° C. for subsequent three-stage fermentation. Among them, the apple is preferably Fuji apple, which has the highest pectin content. First, implant 1% (w/w) yeast ( Saccharomyces cerevisiae , purchased from the Biological Resources Conservation and Research Center, Taiwan, numbered BCRC20271) in the mixed solution. The number of bacteria is preferably 1x10 10 cfu/g. The pre-fermentation is carried out at room temperature for 24 hours, and the actual time varies depending on the fermentation state. Then directly implant 0.5% (w/w) Lactobacillus ( Lactobacillus plantarum TCI028, patent deposited at the Center for Biological Resources Conservation and Research, Taiwan, numbered BCRC910805), the bacterial count is preferably 1x10 11 cfu/g, at room temperature After fermentation is carried out for 24 hours, the actual time varies depending on the fermentation state. Then directly implant 5% (w/w) of Acetobacter sp. ( Acetobacter sp. , purchased from the Biological Resources Conservation and Research Center, Taiwan, numbered BCRC12324), the bacterial count is preferably 1x10 9 cfu/g, at room temperature Submerged fermentation is carried out for 3-5 days, the actual time varies depending on the fermentation state; among them, Lactobacillus TCI028 has been patented in the Republic of China Patent Application No. 106145146. The fermentation sequence of these three bacteria is: yeast, lactobacillus , Acetobacter, and cannot be adjusted back and forth. Finally, without removing these three bacteria, use the set sugar content range <4°, pH<4 and other specifications. If the test meets the specifications, the fermentation is determined to be completed and the fermentation broth is obtained . Next, the fermentation broth was concentrated under reduced pressure at 45-70°C, filtered through a 40-200 mesh screen, and 1% citric acid and 40% isomalt-oligosaccharides were added to adjust the specifications and heated at 95°C for 1.5 hours After sterilization, the fat burning fermented product of the present invention is obtained, which is produced by microbial fermentation to release a large amount of effective substances in the mixture of apple, ginger, pepper, and cinnamon.

實施例2 本發明之燃脂發酵物促進脂肪分解之功效Example 2 The fat burning fermentation product of the present invention has the effect of promoting lipolysis

本發明之一實施例以小鼠骨髓基質細胞OP9細胞進行本發明之發酵三階段步驟提高燃脂發酵物促進脂肪分解之功效測試。該小鼠骨髓基質細胞係購自美國典型培養物保藏中心(美國),編號CRL-2749TM。該細胞於分化前係培養於前脂肪細胞擴增培養液(Pre-adipocyte Expansion Medium),其中包含90%之MEMAM(Minimum Essential Medium Alpha Medium,購自Gibco,美國)細胞培養液、20%之胎牛血清(Fetal Bovine Serum,購自Gibco,美國,Cat#10437-028),且加入0.1%之青黴素/鏈黴素(Penicillin-streptomycin,購自Gibco,美國);並使用分化培養液(Differentiation Medium)使小鼠骨髓基質細胞進行分化,其中包含90%之MEMAM細胞培養液、20%之胎牛血清,且加入0.1% 之青黴素/鏈黴素。使用細胞甘油基檢測試劑套組(Glycerol cell-based assay kit,購自Cayman,美國,產品編號10011725)檢測脂肪細胞分解並釋放至細胞培養液中的甘油量。 An embodiment of the present invention uses mouse bone marrow stromal cells OP9 cells to perform the three-stage fermentation process of the present invention to improve the efficacy of fat burning fermentation products to promote lipolysis. The mouse bone marrow stromal cell line was purchased from the American Type Culture Collection (United States) under the number CRL-2749TM. The cells were cultured in pre-adipocyte expansion medium (Pre-adipocyte Expansion Medium) before differentiation, which contained 90% MEMAM (Minimum Essential Medium Alpha Medium, purchased from Gibco, USA) cell culture medium, 20% fetus Bovine serum (Fetal Bovine Serum, purchased from Gibco, U.S., Cat#10437-028), and adding 0.1% penicillin/streptomycin (Penicillin-streptomycin, purchased from Gibco, U.S.); ) To differentiate mouse bone marrow stromal cells, which contains 90% MEMAM cell culture medium, 20% fetal bovine serum, and 0.1% Of penicillin/streptomycin. The Glycerol cell-based assay kit (purchased from Cayman, USA, product number 10011725) was used to detect the amount of glycerol decomposed by fat cells and released into the cell culture medium.

為證實本發明之燃脂發酵物具有促進脂肪分解的功效,首先將小鼠骨髓基質細胞分化成脂肪細胞,將8x104個小鼠骨髓基質細胞培養於含有500μL上述前脂肪細胞擴增培養液之24孔培養盤中,於37℃下培養7天,且期間每3天更換一次新鮮之上述分化培養液,7天後以顯微鏡觀察脂滴的形成,確保細胞已完全分化,接著將細胞分成以下三組:(1)僅加入細胞培養液之控制組、(2)加入終濃度為0.5%(v/v)之蘋果、薑、辣椒、及肉桂未發酵溶液之比較組、及(3)加入終濃度為0.5%(v/v)之本發明燃脂發酵物之實驗組,並於37℃培養7-10天,且同樣每3天更換一次新鮮之分化培養液。 In order to verify that the fat burning fermentation product of the present invention has the effect of promoting lipolysis, firstly, mouse bone marrow stromal cells were differentiated into adipocytes, and 8 ×10 4 mouse bone marrow stromal cells were cultured in a medium containing 500 μL of the above-mentioned pre-adipocyte expansion medium. In a 24-well culture plate, culture at 37°C for 7 days, and replace the fresh differentiation medium every 3 days during this period. After 7 days, observe the formation of lipid droplets under a microscope to ensure that the cells are fully differentiated, and then divide the cells into the following Three groups: (1) control group with only cell culture solution added, (2) comparison group with apple, ginger, pepper, and cinnamon unfermented solution added at a final concentration of 0.5% (v/v), and (3) addition The experimental group of the fat-burning fermentation product of the present invention with a final concentration of 0.5% (v/v) was cultured at 37°C for 7-10 days, and the fresh differentiation culture medium was also replaced every 3 days.

接著,收集各組細胞液的上清液,並各取其中的25μL轉移到新的96孔培養盤中,並於各孔中加入100μL之重構游離甘油測定試劑(Reconstituted free glycerol assay reagent),再於室溫下作用15分鐘後,將培養盤以ELISA讀數器讀取各組之OD540nm的吸光度,以量化各組脂肪細胞分解並釋放至細胞培養液中的甘油量,並代表脂肪的分解量。其中,利用Excel軟體進行student t-test以決定兩個樣本群體之間是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 Next, collect the supernatant of each group of cell fluids, and transfer 25 μL of each to a new 96-well culture plate, and add 100 μL of Reconstituted free glycerol assay reagent to each well. After 15 minutes at room temperature, the culture plate was used to read the absorbance of each group at OD 540nm with an ELISA reader to quantify the amount of glycerol decomposed by each group of adipocytes and released into the cell culture medium, and represents the decomposition of fat the amount. Among them, use Excel software to perform student t-test to determine whether there is a statistically significant difference between the two sample groups (*p value<0.05; **p value<0.01; ***p value<0.001).

本發明之燃脂發酵物促進脂肪分解的實驗結果如圖1所示。經本發明之燃脂發酵物作用後,相較於控制組,能顯著地提升38%的脂肪分解;而未經過發酵之比較組僅能提升9%的脂肪分解。此結果顯示,本發明之燃脂發酵物在經過特定之微生物發酵步驟後,能直接且有效促進脂肪細胞中脂肪的分解,以減少脂肪細胞中脂肪的含量,而達到燃脂減肥的功效。 The experimental results of the fat burning fermented product of the present invention for promoting fat decomposition are shown in FIG. 1. After the action of the fat burning fermented product of the present invention, compared with the control group, the lipolysis can be significantly increased by 38%; while the comparison group without fermentation can only increase the lipolysis by 9%. This result shows that the fat burning fermented product of the present invention can directly and effectively promote the decomposition of fat in adipocytes, so as to reduce the fat content in adipocytes, and achieve the effect of fat burning and weight loss.

實施例3 本發明之燃脂發酵物調控PLIN1基因及PPARG2基因表現量之功效Example 3 The effect of the fat burning fermentation product of the present invention in regulating the expression of PLIN1 gene and PPARG2 gene

本發明之一實施例為進行本發明之發酵三階段步驟提高燃脂發 酵物調控PLIN1基因及PPARG2基因表現量之功效測試。首先,將1.5x105個OP9細胞培養於6孔培養盤之每孔中,於37℃培養16小時,接著將細胞分成以下三組:(1)僅加入細胞培養液之控制組、(2)加入終濃度為0.5%(v/v)之蘋果、薑、辣椒、及肉桂未發酵溶液之比較組、及(3)加入終濃度為0.5%(v/v)之本發明燃脂發酵物之實驗組,並將該些組別之細胞分別於37℃下作用48小時後,測試各組OP9細胞中PLIN1基因及PPARG2基因的表現量。首先,將OP9細胞以細胞裂解液(RB buffer,購自Geanaid公司,臺灣,Cat No.RBD300)回收細胞後,使用RNA萃取試劑套組(購自Geneaid公司,臺灣,Cat No.RBD300)分別收集該三組細胞內之RNA,接著利用SuperScript® III反轉錄酶(購自Invitrogene公司,美國,編號18080-051)以2000ng之萃取RNA為模板並以引子產生mRNA反轉錄之相應cDNA產物,接著利用ABI StepOnePlusTM Real-Time PCR system(Thermo Fisher Scientific公司,美國),以及KAPA SYBR FAST(購自Sigma公司,美國,編號38220000000)將三組反轉錄後產物分別以表1之組合引子進行定量即時反轉錄聚合酶連鎖反應(Quantitative real-time everse transcription polymerase chain reaction)試驗,條件為95℃反應1秒,60℃反應20秒,總共40個迴圈。用以定量PLIN1基因及PPARG2基因之mRNA表現量,其中定量數值係取由閾值循環數(Cr),而目標基因的mRNA相對量係推導自方程式2-ΔΔCt,其中ΔCT=CT目標基因-CT ACTB (β-肌動蛋白,beta-actin);ΔΔCt=CT比較組或實驗組目標基因-CT控制組目標基因;各組中各基因的fold change則為2-ΔΔCt。接著,再利用Excel軟體決定變異係數與是否在統計上具有顯著差異(*p值<0.05;**p值<0.01;***p值<0.001)。 An embodiment of the present invention is to perform the three-stage fermentation process of the present invention to improve the efficacy of the fat burning ferment to regulate the expression of the PLIN1 gene and the PPARG2 gene. Firstly, 1.5x10 5 OP9 cells were cultured in each well of a 6-well culture plate and cultured at 37°C for 16 hours. Then the cells were divided into the following three groups: (1) Control group with only cell culture medium added, (2) A comparative group of apple, ginger, pepper, and cinnamon unfermented solutions with a final concentration of 0.5% (v/v), and (3) a fat burning fermented product of the present invention with a final concentration of 0.5% (v/v) In the experimental group, the cells of these groups were treated at 37°C for 48 hours, and then the expression levels of PLIN1 and PPARG2 genes in OP9 cells of each group were tested. Firstly, OP9 cells were collected with cell lysate (RB buffer, purchased from Genaid Company, Taiwan, Cat No.RBD300), and then collected using RNA extraction reagent kit (purchased from Geneaid Company, Taiwan, Cat No.RBD300) The three groups of RNA in the cells were then used SuperScript ® III reverse transcriptase (purchased from Invitrogene, USA, No. 18080-051) using 2000ng of extracted RNA as a template and primers to generate the corresponding cDNA products for mRNA reverse transcription, and then use ABI StepOnePlus TM Real-Time PCR system (Thermo Fisher Scientific Company, USA) and KAPA SYBR FAST (purchased from Sigma Company, USA, No. 38220000000) used the three sets of reverse transcription products to perform quantitative real-time reverse reaction with the combination primers in Table 1. In the Quantitative real-time everse transcription polymerase chain reaction test, the conditions are 95°C for 1 second and 60°C for 20 seconds, a total of 40 cycles. It is used to quantify the mRNA expression level of PLIN1 gene and PPARG2 gene, where the quantitative value is taken from the threshold cycle number (Cr), and the relative amount of mRNA of the target gene is derived from equation 2 -ΔΔCt , where ΔC T =C T target gene- C T ACTB (β-actin, beta-actin); ΔΔCt=C T comparison group or experimental group target gene- C T control group target gene ; the fold change of each gene in each group is 2 -ΔΔCt . Then, use Excel software to determine whether the coefficient of variation is statistically significant (*p value<0.05; **p value<0.01; ***p value<0.001).

Figure 108106844-A0101-12-0011-1
Figure 108106844-A0101-12-0011-1

PLIN1(Perilipin 1)基因編碼的蛋白質PLIN1主要功能為調控脂肪細胞中三酸甘油脂的含量以及脂肪分解的反應,其會抑制脂肪的分解並促進脂肪的儲存。因此,PLIN1基因的表現量上升,會促進脂肪細胞中脂肪油滴的擴大,導致脂肪細胞變大、個體變肥胖,若其表現量降低,則可使脂肪油滴變得較容易分解。 The main function of the protein PLIN1 (Perilipin 1) encoded by the PLIN1 (Perilipin 1) gene is to regulate the content of triglycerides in fat cells and the reaction of lipolysis, which inhibits the breakdown of fat and promotes the storage of fat. Therefore, the increase in the expression level of the PLIN1 gene will promote the expansion of fat oil droplets in adipocytes, resulting in fat cells becoming larger and individuals becoming obese. If its expression level is reduced, the fatty oil droplets will become easier to decompose.

PPARG2(Peroxisome proliferator activated receptor gamma 2)基因編碼的蛋白質PPARγ2是過氧化物酶體增殖物激活受體(Peroxisome proliferators-activated receptors,PPARs)的一員,係一種細胞核內的受體,主要功能為調控脂肪的代謝以及脂肪細胞的增殖與分化。其中,PPARγ為PPARs中最對脂肪最具專一性的受體,相較於其他組織或細胞中,PPARγ在脂肪組織及脂肪細胞中具有較高的表現量,經活化之PPARγ會藉由調控脂肪細胞中相關的基因表現,以促進脂肪細胞中脂肪的生成、轉運、儲存及氧化等代謝反應。其中,PPARγ2會促進白色脂肪細胞轉化為棕色脂肪細胞,棕色脂肪能夠燃燒脂肪油滴以產生熱能。因此PPARG2基因的表現量上升,能夠促進脂肪的分解。 The protein encoded by PPARG2 (Peroxisome proliferator activated receptor gamma 2) gene PPARγ2 is a member of Peroxisome proliferators-activated receptors (PPARs), a receptor in the nucleus, and its main function is to regulate fat The metabolism of adipocytes and the proliferation and differentiation of adipocytes. Among them, PPARγ is the most fat-specific receptor among PPARs. Compared with other tissues or cells, PPARγ has a higher expression level in adipose tissue and adipocytes. The activated PPARγ regulates fat The expression of related genes in cells can promote the production, transportation, storage and oxidation of fat in fat cells. Among them, PPARγ2 promotes the conversion of white fat cells into brown fat cells, and brown fat can burn fat oil droplets to generate heat. Therefore, the expression level of PPARG2 gene is increased, which can promote the decomposition of fat.

本發明之燃脂發酵物降低PLIN1基因之表現量的實驗結果如圖2所示;其提升PPARG2基因之表現量的實驗結果則如圖3所示。經本發明之燃脂發酵物作用後,能顯著降低PLIN1基因的表現量達約控制組的0.7倍(降低約 34%),且能顯著的提升PPARG2基因的表現量達控制組的2.2倍;且降低PLIN1基因表現量、及提升PPARG2基因表現量的功效,皆較未經發酵之比較組為佳。此些結果顯示,本發明之燃脂發酵物在經過特定之微生物發酵步驟後,能夠有效的降低脂肪細胞中PLIN1基因的表現量,能促使脂肪油滴變得容易分解,以減少脂肪細胞中脂肪的含量;其亦可同時有效提升PPARG2基因的表現量,能促使白色脂肪細胞轉化為棕色脂肪細胞,以促進脂肪細胞中脂肪的燃燒與分解,因此本發明之燃脂發酵物能用於燃脂減肥的用途。 The experimental result of the fat burning fermentation product of the present invention for reducing the expression of the PLIN1 gene is shown in Figure 2; the experimental result of the improvement of the expression of the PPARG2 gene is shown in Figure 3. After the action of the fat burning fermentation product of the present invention, the expression level of the PLIN1 gene can be significantly reduced by about 0.7 times (about 34%) of the control group, and the expression level of the PPARG2 gene can be significantly increased by 2.2 times that of the control group; and The effect of reducing the expression of PLIN1 gene and increasing the expression of PPARG2 gene is better than the comparison group without fermentation. These results show that the fat burning fermentation product of the present invention can effectively reduce the expression of PLIN1 gene in adipocytes after specific microbial fermentation steps, and can promote the easy decomposition of fatty oil droplets to reduce fat in adipocytes It can also effectively increase the expression of PPARG2 gene at the same time, can promote the conversion of white adipocytes into brown adipocytes, so as to promote the burning and decomposition of fat in adipocytes. Therefore, the fat burning fermentation product of the present invention can be used for fat burning Uses for weight loss.

綜上所述,本發明將蘋果、薑、辣椒、及肉桂之混合物以酵母菌、乳酸桿菌、及醋酸桿菌進行三段式發酵所得之燃脂發酵物,能直接且有效促進脂肪細胞中脂肪的分解、亦能夠有效的降低脂肪細胞中PLIN1基因的表現量,促使脂肪油滴變得容易分解,並能同時有效提升PPARG2基因的表現量,促進白色脂肪細胞轉化為棕色脂肪細胞,使得身體燃燒脂肪的能力上升。因此,本發明之燃脂發酵物能多方面地分解或消耗身體的脂肪,以達到更佳地減肥減脂功效。故,本發明之燃脂發酵物可用於製備燃脂減肥之組合物的用途,且該組合物是一醫藥品、或一食品,可藉由口服、塗抹等方式給予一個體。 In summary, the present invention uses three-stage fermentation of a mixture of apple, ginger, pepper, and cinnamon with yeast, lactobacillus, and acetobacter to obtain the fat burning fermentation product, which can directly and effectively promote the fat in fat cells. Decomposition can also effectively reduce the expression of PLIN1 gene in fat cells, promote the easy decomposition of fatty oil droplets, and effectively increase the expression of PPARG2 gene at the same time, promote the conversion of white fat cells into brown fat cells, and make the body burn fat The ability to rise. Therefore, the fat burning fermented product of the present invention can decompose or consume body fat in various ways, so as to achieve a better weight loss and fat reduction effect. Therefore, the fat-burning fermented product of the present invention can be used to prepare a fat-burning and weight-loss composition, and the composition is a medicine or a food, which can be administered to a body by oral, smearing or the like.

【生物材料寄存】 【Biological Material Deposit】

食品工業發展研究所(台灣);民國106年12月13日;編號BCRC910805 Food Industry Development Research Institute (Taiwan); December 13, 2006; No. BCRC910805

<110> 大江生醫股份有限公司 <110> Dajiang Biomedical Co., Ltd.

<120> 燃脂發酵物及其製備方法與用於燃脂減肥的用途 <120> Fat burning fermented product and its preparation method and its use for fat burning and weight loss

<130> 107B0548-I1 <130> 107B0548-I1

<160> 6 <160> 6

<170> PatentIn version 3.5 <170> PatentIn version 3.5

<210> 1 <210> 1

<211> 19 <211> 19

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 1

Figure 108106844-A0101-12-0013-2
<400> 1
Figure 108106844-A0101-12-0013-2

<210> 2 <210> 2

<211> 23 <211> 23

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 2

Figure 108106844-A0101-12-0014-3
<400> 2
Figure 108106844-A0101-12-0014-3

<210> 3 <210> 3

<211> 20 <211> 20

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 3

Figure 108106844-A0101-12-0014-4
<400> 3
Figure 108106844-A0101-12-0014-4

<210> 4 <210> 4

<211> 21 <211> 21

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 4

Figure 108106844-A0101-12-0014-5
<400> 4
Figure 108106844-A0101-12-0014-5

<210> 5 <210> 5

<211> 20 <211> 20

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 5

Figure 108106844-A0101-12-0015-7
<400> 5
Figure 108106844-A0101-12-0015-7

<210> 6 <210> 6

<211> 22 <211> 22

<212> DNA <212> DNA

<213> 人工序列 <213> Artificial sequence

<220> <220>

<223> 合成引子 <223> Synthetic primer

<400> 6

Figure 108106844-A0101-12-0015-6
<400> 6
Figure 108106844-A0101-12-0015-6

Claims (10)

一種燃脂發酵物,其中該燃脂發酵物係由一蘋果、一薑、一辣椒、及一肉桂所組成之混合物經由一酵母菌(Saccharomyces cerevisiae)、一乳酸桿菌(Lactobacillus plantarum)、及一醋酸桿菌(Acetobacter aceti)依序進行發酵而獲得。 A fat-burning fermentation product, wherein the fat-burning fermentation product is a mixture composed of an apple, a ginger, a pepper, and a cinnamon through a yeast ( Saccharomyces cerevisiae ), a Lactobacillus plantarum , and an acetic acid Bacillus ( Acetobacter aceti ) is obtained by sequentially fermenting. 如申請專利範圍第1項所述之燃脂發酵物,其中該酵母菌之添加量為0.8-1.2%(w/w);該乳酸桿菌之添加量為0.4-0.6%(w/w);該醋酸桿菌之添加量為4-6%(w/w)。 The fat burning fermentation product described in item 1 of the scope of patent application, wherein the addition amount of the yeast is 0.8-1.2% (w/w); the addition amount of the lactobacillus is 0.4-0.6% (w/w); The addition amount of the Acetobacter is 4-6% (w/w). 如申請專利範圍第1項所述之燃脂發酵物,其中該酵母菌係為BCRC20271之菌株;該乳酸桿菌係為BCRC910805之菌株;該醋酸桿菌係為BCRC12324之菌株。 The fat burning fermentation product described in the first item of the patent application, wherein the yeast strain is a strain of BCRC20271; the lactobacillus strain is a strain of BCRC910805; and the acetic acid bacteria strain is a strain of BCRC12324. 一種如申請專利範圍第1項所述之燃脂發酵物用於製備一燃脂減肥之組合物的用途。 A use of the fat burning fermented product described in item 1 of the scope of patent application for preparing a fat burning weight loss composition. 如申請專利範圍第4項所述之用途,其中該燃脂發酵物係促進一脂肪細胞中脂肪的分解。 The use described in item 4 of the scope of patent application, wherein the fat burning fermentation product promotes the decomposition of fat in a fat cell. 如申請專利範圍第5項所述之用途,其中該燃脂發酵物係降低該脂肪細胞中PLIN1基因的表現量、及/或提升該脂肪細胞中PPARG2基因的表現量。 The use described in item 5 of the scope of patent application, wherein the fat burning fermentation product reduces the expression level of the PLIN1 gene in the adipocytes and/or increases the expression level of the PPARG2 gene in the adipocytes. 如申請專利範圍第4項所述之用途,其中該燃脂發酵物之有效濃度為至少0.5%(v/v)。 The use as described in item 4 of the scope of patent application, wherein the effective concentration of the fat burning fermentation product is at least 0.5% (v/v). 一種燃脂發酵物之製造方法,係包含:將一蘋果、一薑、一辣椒、及一肉桂所組成之混合物經由一酵母菌、一乳酸桿菌、及一醋酸桿菌依序進行三階段發酵而獲得。 A method for manufacturing fat burning fermented product, comprising: a mixture of an apple, a ginger, a pepper, and a cinnamon is obtained by sequentially performing a three-stage fermentation of a yeast, a lactobacillus, and an acetobacter . 如申請專利範圍第8項所述之製造方法,其中該酵母菌之添加量為0.8-1.2%(w/w);該乳酸桿菌之添加量為0.4-0.6%(w/w);該醋酸桿菌之添加量為4-6%(w/w)。 The manufacturing method described in item 8 of the scope of patent application, wherein the addition amount of the yeast is 0.8-1.2% (w/w); the addition amount of the lactobacillus is 0.4-0.6% (w/w); the acetic acid The amount of bacillus added is 4-6% (w/w). 如申請專利範圍第8項所述之製造方法,其中該酵母菌、該乳酸桿菌、及該醋酸桿菌之發酵時間比為1-3:1-3:3-5。 The manufacturing method described in item 8 of the scope of patent application, wherein the fermentation time ratio of the yeast, the lactobacillus, and the acetobacter is 1-3:1-3:3-5.
TW108106844A 2019-02-27 2019-02-27 Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight TWI690589B (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
TW108106844A TWI690589B (en) 2019-02-27 2019-02-27 Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight
CN201910357881.5A CN111617218A (en) 2019-02-27 2019-04-28 Fat burning fermentation product, preparation method thereof and application of fat burning fermentation product in preparation of fat burning weight reducing composition

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
TW108106844A TWI690589B (en) 2019-02-27 2019-02-27 Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight

Publications (2)

Publication Number Publication Date
TWI690589B TWI690589B (en) 2020-04-11
TW202031887A true TW202031887A (en) 2020-09-01

Family

ID=71134488

Family Applications (1)

Application Number Title Priority Date Filing Date
TW108106844A TWI690589B (en) 2019-02-27 2019-02-27 Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight

Country Status (2)

Country Link
CN (1) CN111617218A (en)
TW (1) TWI690589B (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW202128202A (en) * 2020-01-16 2021-08-01 大江生醫股份有限公司 Use of cyclocarya paliurus extract for enhancing the expression level of fat loss gene, increasing basal metabolic rate, and/or suppressing fat accumulation

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102940288B (en) * 2012-11-19 2013-10-30 商丘市饮之健食品有限公司 Composite enzyme beverage and preparation process method thereof
CN102994362B (en) * 2012-12-06 2014-03-12 陕西科技大学 Method for fermenting apple vinegar
CN104222278A (en) * 2014-10-01 2014-12-24 青岛嘉瑞生物技术有限公司 Milk vinegar and green tea health drink with weight-losing function
CN104286756A (en) * 2014-11-06 2015-01-21 天津天绿健科技有限公司 Weight-losing fruit and vegetable powder
CN104509924A (en) * 2014-11-07 2015-04-15 西北农林科技大学 Starter culture, preparation method and application thereof
CN104489161A (en) * 2014-12-11 2015-04-08 贵州三清源生态农业科技开发有限责任公司 Scented tea enzyme drink and preparation method thereof
CN104621651B (en) * 2015-01-26 2016-08-17 江苏大学 A kind of method utilizing multiple bacteria compound fermentation to prepare Fig Vinegar beverage
CN104997120A (en) * 2015-07-06 2015-10-28 青岛嘉瑞生物技术有限公司 Production technology of enteromorpha prolifra fermented beverage prepared by mixed bacteria asynchronous fermentation
CN105029575B (en) * 2015-07-10 2018-01-23 韦柳昌 A kind of apple myrtle fruit vinegar beverage and preparation method thereof
CN105942496A (en) * 2016-04-29 2016-09-21 辽宁晟启昊天生物医药科技有限公司 Ferment product with strong antioxidant activity and preparation method of ferment product
US20180221276A1 (en) * 2017-02-07 2018-08-09 Drink NOVE, LLC Wellness drink and method of manufacture
CN107439896A (en) * 2017-08-23 2017-12-08 无为黄老头风味食品有限公司 One kind fat-reducing skin care thick chilli sauce and preparation method thereof
CN108142934A (en) * 2018-01-09 2018-06-12 中博绿色科技股份有限公司 A kind of light spot skin makeup Kiwi berry ferment and its preparation process of invigorating blood circulation

Also Published As

Publication number Publication date
TWI690589B (en) 2020-04-11
CN111617218A (en) 2020-09-04

Similar Documents

Publication Publication Date Title
CN1980682A (en) Flaxseeds for body weight management
KR102130332B1 (en) Health fuctional food composition for preventing or improving liver diseases comprising Gastrodia elata and larva
Lagos et al. Recent patents on the application of bioactive compounds in food: a short review
CN105853467B (en) Lactobacillus reuteri GMNL-263 is used to prepare the purposes of blood-fat reducing composition
KR102180223B1 (en) Anti-obesity composition comprising extract of Sargassum horneri
CN105595047A (en) Feed for meat geese
TWI690589B (en) Fat burning ferment, preparation method thereof and use thereof for fat burning and losing weight
KR20160059137A (en) MANUFACTURE OF FERMENTED Alliumhookeri FROM LACTIC ACID BACTERIA AND NATURAL ENZYME AND PREPARATION OF COMBINED BEVERAGE FOR QUENCHING THIRST
CN107259182A (en) Broiler fodder
CN106993734B (en) Whole wheat beverage powder
JP2022173294A (en) Antiallergic agent, intestinal immunoenhancer, intestinal adhesiveness improver of lactic acid bacteria
CN102302114A (en) Pollen-containing health-care food and preparation method thereof
CN102652561A (en) Vegetable protein food for treating micro-disease or assisting medicament in rehabilitating sick body and production method thereof
WO2022075096A1 (en) Raldh2 expression enhancing agent
CN108272088A (en) Special diet for labour packet
TWI764520B (en) Uses of a plant fermentation liquid in preparing composition for improving metabolism
EP3542811B1 (en) Black rice sprouting liquid having anti-inflammatory effect and manufacturing method thereof
KR101392715B1 (en) A composotion for the treatment of obesity comprising the coicis semen complex
CN112190644A (en) Plant fermentation product, preparation method thereof and application of plant fermentation product in stomach health care
KR101391647B1 (en) Anti obesity composition
CN105724539A (en) Blood sugar reducing dietary biscuits and preparation method therefor
KR20220052606A (en) Bamboo salt Laver-bugak comprising Ginkgo and Bellflower and Manufacturing method of the same
KR102337130B1 (en) Composition comprising fermented Oriental medicine herbs for preventing, improving or treating obesity, and method for preparing the same
KR20190054997A (en) Allii Fistulosi Bulbus porridge composition for promting osteogenesis
KR102660590B1 (en) Color fermented product, and the body fat reduction composition containing active ongredients the fermented product